Harikanta Overseas IPO Day 2: GMP ₹0

Welcome back to our daily check-in on the Harikanta Overseas SME IPO! As we close out Day 2 of the subscription period, the picture remains quite subdued. With the IPO open for bidding until May 22nd, 2026, investors still have a bit of time to consider their options. However, as of this morning, the subscription books haven’t seen any significant movement. Let’s dive into the details and see what this means for potential applicants.

Subscription Status

The subscription figures for Harikanta Overseas on Day 2 are, to put it mildly, flat. We’re seeing 0x subscription across all categories: Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This means that not a single share has been subscribed for yet in any segment. For an SME IPO, especially one with a lot size of 1200 shares, this kind of early-stage subscription can be a point of concern. Typically, by the second day, we’d expect to see at least some initial interest, even if it’s modest.

The lack of QIB and NII interest, in particular, is something to watch. These are often the more informed investors who can signal market sentiment. Their silence so far doesn’t necessarily spell doom, but it does suggest a cautious approach from their end. Retail investors, who usually come in later, are also yet to show their hand. The total subscription stands at a flat 0x, indicating that the IPO is still waiting for its first application.

GMP Update

Moving on to the Grey Market Premium (GMP), the situation is equally uneventful. The current GMP for Harikanta Overseas is ₹0. Yesterday, it was also reported at ₹0, so we’ve seen no change. A GMP of ₹0 means that, in the unofficial market, there’s no premium being paid over the issue price of ₹91. This implies that the market sentiment, as reflected by the GMP, is currently neutral. Investors aren’t expecting the stock to list at a premium, nor are they anticipating a discount.

The expected listing price, based on the current GMP, remains at the issue price of ₹91. While a ₹0 GMP isn’t ideal for those seeking immediate listing gains, it’s also not necessarily a red flag on its own, especially for an SME IPO. It simply suggests that the market is waiting for more concrete signals or a clearer understanding of the company’s prospects before assigning any premium.

Should You Apply?

So, the big question: should you be applying for Harikanta Overseas at this stage? The data so far presents a mixed bag, leaning towards caution. The subscription numbers are undeniably weak for Day 2, which is unusual. Combined with a ₹0 GMP, it suggests that the market isn’t overtly excited about this offering just yet. The expected listing price is at par with the issue price, meaning you’re unlikely to see immediate profits on listing day based on current sentiment.

However, it’s important to remember that the IPO period extends until May 22nd, 2026. There’s still time for interest to pick up, especially in the last day or two, which is common for many IPOs. If you’re a long-term investor with a strong conviction in Harikanta Overseas’ business fundamentals, the current lack of subscription might even present an opportunity to get in at a potentially less crowded stage. That said, for those primarily looking for listing gains, the current indicators are not very encouraging.

As always, it’s wise to do your own due diligence on the company’s financials, management, and future prospects. Consulting with a SEBI registered investment advisor can also provide valuable insights tailored to your investment goals. Don’t forget to check out the full details and analysis on Harikanta Overseas IPO.